Orion

Latest news

• 
  Orion Corporation completed share acquisitions (opens in a new tab)

  GlobeNewswire · Sep 30, 2026

• Orion Oyj:n omien osakkeiden hankinta päättynyt (opens in a new tab)

  globenewswire.com · Sep 30, 2026

• 
  Orion Corporation: Acquisition of own shares during week 40, 2026 (opens in a new tab)

  GlobeNewswire · Sep 30, 2026

• Orion Oyj: Omien osakkeiden hankinta viikolla 40/2026 (opens in a new tab)

  globenewswire.com · Sep 30, 2026

• 
  Orion Oyj (HLSE:ORNBV) Has Investors Asking Questions (opens in a new tab)

  Simply Wall St. · Sep 26, 2026

• Näkyykö Saturnus, Orion tai Vega? Nyt on tähtiharrastuspäivä (opens in a new tab)

  Kaleva · Sep 26, 2026

• Orion Oyj: Omien osakkeiden hankinta viikolla 39/2026 (opens in a new tab)

  globenewswire.com · Sep 25, 2026

• 
  Orion Corporation: Acquisition of own shares during week 39, 2026 (opens in a new tab)

  GlobeNewswire · Sep 25, 2026

• 
  Orion Corporation: Acquisition of own shares during week 38, 2026 (opens in a new tab)

  GlobeNewswire · Sep 18, 2026

• 
  Orion Corporation: Acquisition of own shares during week 37, 2026 (opens in a new tab)

  GlobeNewswire · Sep 11, 2026

• Orion Corporation: Acquisition of own shares during week 36, 2026 (opens in a new tab)

  Sep 4, 2026

• 102,000 Orion Corporation A shares converted into B shares (opens in a new tab)

  Sep 4, 2026

• Orion Corporation to commence acquisition of own shares for its share-based incentive plans (opens in a new tab)

  Aug 27, 2026

• 
  Orion Group Half-Year Financial Report January–June 2026 (opens in a new tab)

  GlobeNewswire · Jul 17, 2026

• 
  Orion Corporation’s financial reporting and Annual General Meeting in 2027 (opens in a new tab)

  GlobeNewswire · Jul 17, 2026

• 
  45,611 Orion Corporation A shares converted into B shares (opens in a new tab)

  GlobeNewswire · Jul 15, 2026

• 
  Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026 (opens in a new tab)

  GlobeNewswire · Jul 3, 2026

• 
  Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market (opens in a new tab)

  GlobeNewswire · Jun 30, 2026

• Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting (opens in a new tab)

  May 21, 2026

• 
  Orion Corporation: Managers’ transactions – Veli-Matti Mattila (opens in a new tab)

  GlobeNewswire · May 4, 2026